Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
A defect of CD16-positive monocytes can occur without disease.
Frankenberger M, Ekici AB, Angstwurm MW, Hoffmann H, Hofer TP, Heimbeck I, Meyer P, Lohse P, Wjst M, Häussinger K, Reis A, Ziegler-Heitbrock L. Frankenberger M, et al. Immunobiology. 2013 Feb;218(2):169-74. doi: 10.1016/j.imbio.2012.02.013. Epub 2012 Feb 28. Immunobiology. 2013. PMID: 22459269
The CD16-positive monocytes have been first described in 1988 but to date no selective defect in the number of these cells in blood has been reported. ...The data indicate that the absence of CD16-positive monocytes in blood does n …
The CD16-positive monocytes have been first described in 1988 but to date no selective defect in the number of t …
Proinflammatory CD14+CD16+ monocytes are associated with microinflammation in patients with type 2 diabetes mellitus and diabetic nephropathy uremia.
Yang M, Gan H, Shen Q, Tang W, Du X, Chen D. Yang M, et al. Inflammation. 2012 Feb;35(1):388-96. doi: 10.1007/s10753-011-9374-9. Inflammation. 2012. PMID: 21847775
Following the exposure to LPS, PBMCs showed a significant upregulation in NF-kappaB-p65 and p-STAT5 expression and a remarked increase in Supernatants IL-6 level, in a positive correlation with disease severity. Our results suggest that the disturbance in proinflamm …
Following the exposure to LPS, PBMCs showed a significant upregulation in NF-kappaB-p65 and p-STAT5 expression and a remarked increase in Su …